Tango Therapeutics TNGX Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $112.28M+61.5% | $69.53M+4.7% | $66.39M+10.7% | $59.97M-58.0% | ||
| $230.86M+22.5% | $188.39M-30.4% | $270.5M-11.6% | $306.17M-10.6% | ||
| $353.76M+32.8% | $266.34M-23.1% | $346.54M-7.7% | $375.27M-23.8% | ||
| $6.87M-15.2% | $8.1M-18.2% | $9.91M-9.0% | $10.88M+125% | ||
| $398.69M+26.0% | $316.49M-21.4% | $402.57M-7.8% | $436.47M-12.7% | ||
| $21.68M-43.2% | $38.17M-16.9% | $45.94M-17.3% | $55.55M+36.5% | ||
| $52.51M-55.1% | $116.98M-21.7% | $149.46M-20.1% | $186.99M+20.3% | ||
| 200M+185,085% | 108K+5.9% | 102K+15.9% | 88K0.0% | ||
| -$603.15M-20.3% | -$501.56M-35.1% | -$371.26M-37.8% | -$269.51M-67.1% | ||
| $346.18M+73.5% | $199.52M-21.2% | $253.11M+1.5% | $249.48M-27.6% | ||
| $398.69M+26.0% | $316.49M-21.4% | $402.57M-7.8% | $436.47M-12.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Tango Therapeutics cover its short-term obligations?
- Its current ratio is 27.38 — current assets exceed current liabilities.
- Where does Tango Therapeutics's balance sheet data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.